OYST

Oyster Point Pharma Inc.

Price

return (12m)

p/e

-1.70

p/bv

-13.50

DIVIDEND YIELD

0.00%

OYST price

Oyster Point Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment OYST

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals OYST

Valuation

P/E

-1.70

Sector -3.10

Industry -3.10

P/BV

-13.50

Sector 1.77

Industry 1.77

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

-9.53

Sector -216.68

Industry -216.68

EV/EBIT

-9.49

Sector -46.14

Industry -46.14

P/EBITDA

-1.86

Sector -21.54

Industry -21.54

P/EBIT

-1.86

Sector -27.94

Industry -27.94

P/Total Assets

2.74

Sector 1.05

Industry 1.05

P/Net Current Assets

Sector -9.24

Industry -9.24

P/Working Capital

Sector -135.45

Industry -135.45

EPS

-6.58

Sector -1.78

Industry -1.78

BVPS

-0.83

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

100.00%

Sector 41.24%

Industry 41.24%

EBITDA Margin

-606.56%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

-100.00%

Sector -35.37%

Industry -35.37%

Net Profit Margins

-100.00%

Sector -35.81%

Industry -35.81%

Asset Turnover

0.05

Sector 0.03

Industry 0.03

Profitability

ROE

795.63%

Sector -57.47%

Industry -57.47%

ROA

-161.76%

Sector -59.48%

Industry -59.48%

ROIC

Sector -2,385.22%

Industry -2,385.22%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.92

Industry 2.92

Net Debt / EBITDA

-0.69

Sector -21.38

Industry -21.38

Net Debt / EBIT

-0.69

Sector -8.29

Industry -8.29

Net Debt / Equity

-1.05

Sector -33,113.00

Industry -33,113.00

Gross Debt / Equity

-4.15

Sector -0.84

Industry -0.84

Equity/Assets

-0.20

Sector 0.46

Industry 0.46

Liabilities/Assets

-0.20

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

24.25%

Sector -

Industry -

5Y Earnings CAGR

11.91%

Sector -

Industry -

Fundamentals OYST

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
OYST Oyster Point Pharma Inc.	$0.00	-	0.00%	-1.70	-13.50	795.63%	-100.00%
PFE Pfizer Inc.	$29.30	29.93%	5.91%	38.29	1.94	5.07%	6.80%
ABBV AbbVie Inc.	$283.02	27.22%	2.40%	79.71	-84.84	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.44	-25.78%	4.74%	9.57	5.08	53.11%	35.32%
MRK Merck & Co. Inc.	$144.69	75.65%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$165.06	-0.87%	1.95%	19.76	5.09	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$58.66	42.28%	4.19%	13.18	5.48	41.59%	18.87%
ZTS Zoetis Inc.	$79.45	-43.79%	2.64%	12.52	10.49	83.77%	27.69%
AMGN Amgen Inc.	$426.52	46.68%	2.29%	26.86	20.10	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$782.52	35.91%	0.47%	18.88	2.58	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$122.82	83.23%	0.00%	34.40	99.12	288.13%	24.86%
MCK McKesson Corporation	$994.67	27.04%	0.34%	25.91	-30.79	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$502.58	20.58%	0.00%	29.00	6.31	21.76%	35.00%
CAH Cardinal Health Inc.	$250.05	61.38%	0.81%	34.89	-21.95	-62.92%	0.67%
ARGX argenx SE	$820.58	-2.74%	0.00%	13.83	3.67	26.52%	25.54%
HRMY Harmony Biosciences Holdings Inc.	$37.50	44.79%	0.00%	12.22	2.22	18.14%	18.88%
BIIB Biogen Inc.	$232.87	62.85%	0.00%	41.65	1.84	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

OYST - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Oyster Point Pharma

Oyster Point Pharma Inc.

Average Investor10 user rating

4.0 (0 people)

United States

11 years

Founded: 2015

2019

Time since IPO - 7 years

30

Employees

Oyster Point Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $299.70 million, with shareholders equity totaling $-22.20 million.

The company employs approximately 30 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Oyster Point Pharma Inc. reported $19.58 million in revenue, generating net income of $-176.65 million.

Key financial metrics include a P/E ratio of -1.70, a price-to-book (P/B) ratio of -13.50, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker OYST.

Market cap

$299.70 million

Net worth

$-22.20 million

$-22,202,000.00

Assets

$109.20 million

$109,201,000.00

Total Shares Outstanding

26.83 million

26,830,000

Average Daily Trading Volume

$177.27 Thousand

$177,269.70

Sector

Health Care

Industry

Biotechnology

OYST

OYST revenue and profits

Financial Results OYST

DRAG THE FRAME TO SEE MORE DATA

OYST cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$994.67 27,04% (12M)

P/E

25.91

0.34%

ROE

-118.84%

P/BV

-30.79

CAH - Cardinal Health

$250.05 61,38% (12M)

P/E

34.89

0.81%

ROE

-62.92%

P/BV

-21.95

ABBV - AbbVie

$283.02 27,22% (12M)

P/E

79.71

2.40%

ROE

-106.44%

P/BV

-84.84

MRK - Merck & Co.

$144.69 75,65% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$165.06 0,10% (12M)

P/E

19.76

1.95%

ROE

25.77%

P/BV

5.09

PFE - Pfizer

$29.30 29,93% (12M)

P/E

38.29

5.91%

ROE

5.07%

P/BV

1.94

BMY - Bristol-Myers Squibb

$58.66 42,28% (12M)

P/E

13.18

4.19%

ROE

41.59%

P/BV

5.48

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$994.67 27,04% (12 M)

P/L

25.91

0.34%

ROE

-118.84%

P/VP

-30.79

CAH - Cardinal Health

$250.05 61,38% (12 M)

P/L

34.89

0.81%

ROE

-62.92%

P/VP

-21.95

ABBV - AbbVie

$283.02 27,22% (12 M)

P/L

79.71

2.40%

ROE

-106.44%

P/VP

-84.84

MRK - Merck & Co.

$144.69 75,65% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$165.06 0,10% (12 M)

P/L

19.76

1.95%

ROE

25.77%

P/VP

5.09

PFE - Pfizer

$29.30 29,93% (12 M)

P/L

38.29

5.91%

ROE

5.07%

P/VP

1.94

BMY - Bristol-Myers Squibb

$58.66 42,28% (12 M)

P/L

13.18

4.19%

ROE

41.59%

P/VP

5.48

Frequently Asked Questions

What is the price of Oyster Point Pharma (OYST) today?

The current price of Oyster Point Pharma (OYST) is $0.00. The stock began the year trading around $0.00 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Oyster Point Pharma (OYST) pay dividends?

Oyster Point Pharma (OYST) did not pay dividends over the past year.

Is Oyster Point Pharma (OYST) a good investment?

Oyster Point Pharma (OYST) is currently trading at $0.00 with a P/E ratio of -1.70. This represents a -170% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Oyster Point Pharma (OYST) stock?

You can buy Oyster Point Pharma (OYST) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol OYST and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Oyster Point Pharma (OYST) yield today?

Over the past month, Oyster Point Pharma (OYST) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Oyster Point Pharma (OYST) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

OYST

Oyster Point Pharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment OYST

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING OYST WITH OTHER STOCK

ABOUT Oyster Point Pharma

Oyster Point Pharma Inc.

United States

11 years

2019

30

PROFIT X PRICE OYST

Financial Results OYST

OYST cash flow

Asset, Revenue and Profit Growth - OYST

OYST balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions